CatalystPit

ORKAOruka Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $83.29 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$5.51B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-02 · Klein Lawrence Otto (Chief Executive Officer) · SELL
  • 2026-10-02 · Klein Lawrence Otto (Chief Executive Officer) · OTHER
  • 2026-09-21 · Quinlan Paul T (General Counsel) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders261
Shares held76,678,420
Value$6.89B
Percent of shares outstanding115.81%
As of quarter end2026-06-30
RECENT NEWS
  • Oruka Therapeutics CEO Klein sells $2.09m in stock
  • Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
  • Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock
  • Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock
  • Oruka Therapeutics CEO Lawrence Klein sells $234,680 in stock
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Oruka Therapeutics, Inc. (ORKA) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit